Urinary Tract Infection (UTI) and Antibiotic Resistance Panel
This qPCR panel tests urine samples and can detect the presence of 17 bacteria and 36 antibiotic resistance genes down to low colony-forming unit (cfu) numbers that culturing is unable to detect.
Results are formatted in an easy-to-read report that helps guide the physician in treating their patient for a urinary tract infection. Based on the presence of bacteria and antibiotic resistance genes in a patient’s sample, it can be determined which antibiotics are likely to be effective or ineffective in treating the infection. An absence of detection does not imply the absence of microorganisms other than those listed, however, and does not exclude the possibility that the target sequence is present below the limit of detection.
The UTI Diagnostic Report does not take into consideration patient history, drug-drug interactions, drug sensitivity, and/or allergies. It is the responsibility of the physician to determine appropriate drug and dosing choices based on all available data.
Specimen Requirements: Minimum of 2 mL of urine from patient, provided in a sterile urine collection container.
Klebsiella (Enterobacter) aerogenes
Extended Spectrum Beta-lactamase
Quinolone & Fluoroquinolone Resistance
We offer comprehensive UTI testing panels that not only detect common pathogens, but also provide crucial information on antibiotic resistance, empowering clinicians with the data they need to make informed treatment decisions and combat antibiotic resistance effectively.
Indications for Molecular UTI Panel
Over 50 years of age
Chronic Pain Patients
Turnaround time is 24-72 hours